Is PLRX or PPBT more undervalued in 2026?

CirclFi compares Pliant Therapeutics, Inc. (PLRX) and Purple Biotech Ltd. (PPBT) using 13 institutional-grade valuation models. PLRX has a Quality of Company score of 4.3/10 while PPBT scores 3.6/10.

Which is a better buy — PLRX or PPBT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do PLRX and PPBT valuations compare?

PLRX at $1.26 and PPBT at $2.99 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

PLRX vs PPBT Valuation Comparison 2026 — Intrinsic Value Analysis

PLRX

Pharmaceutical Preparations

Pliant Therapeutics, Inc.

Quality

4.3

out of 10

Value Trap

LOW

Price

$1.26

Last close

Models

7/13

Active

PPBT

Pharmaceutical Preparations

Purple Biotech Ltd.

Quality

3.6

out of 10

Value Trap

—

Price

$2.99

Last close

Models

2/13

Active

Model-by-Model Comparison

Model	Type	PLRX Fair Value	PLRX Upside	PPBT Fair Value	PPBT Upside
Bayesian DCF	Intrinsic	$0.10	-91.8%	—	—
EROIC Spread	Intrinsic	—	—	$1.28	-57.1%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$2.32	+83.8%	$0.54	-80.7%
Dynamic NAV	Asset-Based	$3.22	+155.6%	—	—
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for PLRX vs PPBT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PLRX vs PPBT — Which Stock Is More Undervalued?

PLRX scores higher with a 4.3/10 quality rating vs PPBT's 3.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Pliant Therapeutics, Inc. (PLRX) and Purple Biotech Ltd. (PPBT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PLRX currently trades at $1.26 with a QOC of 4.3/10, while PPBT trades at $2.99 with a QOC of 3.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).